1 duplicate copy in the archive
Generic cannabinoid overview from Ackrell Capital with no evident investigative leads
Title Matchkaggle-ho-024657
Case Filed-28725House OversightGeneric cannabinoid overview from Ackrell Capital with no evident investigative leads
November 11, 20251p3 persons
Case File
d-28725House OversightGeneric cannabinoid overview from Ackrell Capital with no evident investigative leads
Other
The passage is a standard informational summary of cannabis compounds produced by Ackrell Capital, containing no names, transactions, dates, or allegations linking powerful actors to misconduct. It of Describes therapeutic properties of CBD, CBC, CBG, CBGA, CBN, and THCA. Notes non‑psychoactive nature of most listed cannabinoids and potential medical applications. Mentions Ackrell Capital, LLC as
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024657
Pages
1
Persons
3
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.